Please login to the form below

Not currently logged in
Email:
Password:

NHSE

This page shows the latest NHSE news and features for those working in and with pharma, biotech and healthcare.

Vertex scores FDA approval for CF triple therapy Trikafta

Vertex scores FDA approval for CF triple therapy Trikafta

Trikafta is priced similarly to Kalydeco – Vertex and NHS England (NHSE) reached a pricing deal for this first CF drug in 2013. ... However, since then NHSE’s specialised commissioning head John Stewart has said that it overpaid for Kalydeco.

Latest news

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest Intelligence

  • The UK’s new medicines pricing deal – opportunities and risks for pharma The UK’s new medicines pricing deal – opportunities and risks for pharma

    This is further evidence of the influence of NHSE. New incentives to greater cost-effectiveness. ... A single point of contact with NHSE and NICE offering greater consistency and clarity of advice.

  • Vertex: a vision of treating all CF patients worldwide draws closer Vertex: a vision of treating all CF patients worldwide draws closer

    After its grilling of Jeff Leiden and his NHSE and NICE counterparts, the chair of the health select committee, Dr Sarah Wollaston MP wrote to the health secretary suggesting the government

  • The Orkambi row explained The Orkambi row explained

    April 2018: Vertex meets with NHSE to discuss access to Orkambi and future treatments. ... March 2019: Vertex, NHSE and NICE meet with Matt Hancock to recommence discussions on cystic fibrosis medicines.

  • #OrkambiNow? #OrkambiNow?

    Fast forward to July 2018, and the row had escalated to the point where Vertex branded NHSE’s behaviour as ‘outrageous’ and ‘unconscionable’.

  • NHS regional footprints NHS regional footprints

    What to expect from 2019. Towards the end of 2018, a map was published by NHS England (NHSE) and NHS Improvement (NHSI), which divided the country into 42 ‘regional footprints’ responsible ... The widening role of CCGs was underlined by the recent

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Windrose Consulting Group

Windrose Consulting Group helps life science companies maximize the commercial value of their products and bring new innovations to market...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics